In vivo effects of adenosine 5 ́-triphosphate on rat preneoplastic liver;Efecto in vivo de adenosina 5 ́-trifosfato sobre el hígado preneoplásico de la rata

Medicina

Volumn 71, Issue 2, 2011, Pages 139-145

  Frontini, Ana V ^a   de la Vega Elena, Carlos D ^a   Nicolorich, Maria V ^a   Naves, Ariel ^a   Schwarzbaum, Pablo ^b   Venera, Graciela D ^a,b  

^a Instituto Universitario Italiano de Rosario   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Adenosine; Altered hepatocytes foci; Apoptosis; ATP; Hepatocarcinoma; Preneoplastic foci; Preneoplastic model; Proliferation

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; CYCLINE; GLUTATHIONE TRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; LIVER CANCER; LIVER CARCINOGENESIS; MALE; MALIGNANT TRANSFORMATION; NONHUMAN; PRECANCER; RAT; TREATMENT DURATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; GLUTATHIONE TRANSFERASE; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PRECANCEROUS CONDITIONS; RABBITS; RATS; RATS, WISTAR;

EID: 79958725743     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002; 35: S72-8.
2. Borbath I, Leclercq IA, Abarca-Quinones J, et al. Inhibition of early preneoplastic events in the rat liver by the somatostatin analog lanreotide. Cancer Sci 2007; 98: 1831-9.
3. Altmann HW. Hepatic neoformations. Pathol Res Pract 1994; 190: 513-77.
4. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002; 31: 339-46.
5. Alvarez ML, Cerliani JP, Monti JA, et al. [In vivo apoptotic effect of alpha-2b interferon (IFN) on rat preneoplastic liver]. Medicina (Buenos Aires) 2001; 61: 666-9.
6. Rao PM, Nagamine Y, Roomi MW, et al. Orotic acid, a new promoter for experimental liver carcinogenesis. Toxicol Pathol 1984; 12: 173-8.
7. Ito N, Tsuda H, Tatematsu M, et al. Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats-an approach for a new medium-term bioassay system. Carcinogenesis 1988; 9: 387-94.
8. Solt D, Farber E. New principle for the analysis of chemical carcinogenesis. Nature 1976; 263: 701-3.
9. Rapaport E. Anticancer activities of adenine nucleotides in tumor bearing hosts. Drug Dev Res 1993; 28: 428-31.
10. Abraham EH, Salikhova AY, Rapaport E. ATP in the treatment of Advanced Cancer. Curr Top Membr 2003; 54: 415-52.
11. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 2006; 58: 58-86.
12. Deli T, Csernoch L. Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors. Pathol Oncol Res 2008; 14: 219-31.
13. Zimmermann H. Ectonucleotidases: Some recent developments and a note on nomenclature. Drug Dev Res 2001; 52: 44-56.
14. Ohta A, Gorelik E, Prasad SJ, et al. A2A adenosine receptor protects tumors from antitumor T cells. Proc Natl Acad Sci U S A 2006; 103: 13132-7.
15. Lasso de la Vega MC, Terradez P, Obrador E, et al. Inhibition of cancer growth and selective glutathione depletion in Ehrlich tumour cells in vivo by extracellular ATP. Biochem J 1994; 298: 99-105.
16. Obrador E, Navarro J, Mompo J, et al. Glutathione and the rate of cellular proliferation determine tumour cell sensitivity to tumour necrosis factor in vivo. Biochem J 1997; 325 (Pt 1): 183-9.
17. Beijer S, Gielisse EA, Hupperets PS, et al. Intravenous ATP infusions can be safely administered in the home setting: a study in pre-terminal cancer patients. Invest New Drugs 2007; 25: 571-9.
18. Imai T, Masui T, Ichinose M, et al. Reduction of glutathione S-transferase P-form mRNA expression in remodeling nodules in rat liver revealed by in situ hybridization. Carcinogenesis 1997; 18: 545-51.
19. Pitot HC. Altered hepatic foci: their role in murine hepatocarcinogenesis. Annu Rev Pharmacol Toxicol 1990; 30: 465-500.
20. Saltykov SA. The determination of the size distribution of particles in an opaque material from a measurement of the size distribution of their sections. In: H E, (ed.) Proceedings of the Second International Congress on Stereology. Berlin: Springer-Verlag, 1967: 153-73.
21. Xu YH, Campbell HA, Sattler GL, et al. Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers. Cancer Res 1990; 50: 472-9.
22. Dragan YP, Hully JR, Nakamura J, et al. Biochemical events during initiation of rat hepatocarcinogenesis. Carcinogenesis 1994; 15: 1451-8.
23. Robbins BA, de la Vega D, Ogata K, et al. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med 1987; 111: 841-5.
24. Greenwell A, Foley JF, Maronpot RR. An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett 1991; 59: 251-6.
25. Hacker G. The morphology of apoptosis. Cell Tissue Res 2000; 301: 5-17.
26. Wen LT, Knowles AF. Extracellular ATP and adenosine induce cell apoptosis of human hepatoma Li-7A cells via the A3 adenosine receptor. Br J Pharmacol 2003; 140: 1009-18.
27. Zheng LM, Zychlinsky A, Liu CC, et al. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 1991; 112: 279-88.
28. Rapaport E, Fontaine J. Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools. Proc Natl Acad Sci U S A 1989; 86: 1662-6.
29. Becker EP, Sun D, Minuk GY. Exogenous adenosine 5'-triphosphate does not improve survival in rats with acute liver failure. Dig Dis Sci 2008; 53: 794-8.
30. Agteresch HJ, Dagnelie PC, van den Berg JW, Wilson JH. Adenosine triphosphate: established and potential clinical applications. Drugs 1999; 58: 211-32.
31. Nakaji M, Yano Y, Ninomiya T, et al. IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat. Carcinogenesis 2004; 25: 389-97.
32. Sakakima Y, Hayakawa A, Nagasaka T, Nakao A. Prevention of hepatocarcinogenesis with phosphatidylcholine and menaquinone-4: in vitro and in vivo experiments. J Hepatol 2007; 47: 83-92.
33. Eguchi Y, Srinivasan A, Tomaselli KJ, et al. ATP-dependent steps in apoptotic signal transduction. Cancer Res 1999; 59: 2174-81.
34. Calvisi DF, Pinna F, Pellegrino R, et al. Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control. Int J Cancer 2008; 123: 2057-64.
35. White N, Burnstock G. P2 receptors and cancer. Trends Pharmacol Sci 2006; 27: 211-7.
36. Emmett DS, Feranchak A, Kilic G, et al. Characterization of ionotrophic purinergic receptors in hepatocytes. Hepatology 2008; 47: 698-705.
37. Burnstock G. Unresolved issues and controversies in purinergic signalling. J Physiol 2008; 586: 3307-12.
38. Schulte-Hermann R, Bursch W, Kraupp-Grasl B, et al. Cell proliferation and apoptosis in normal liver and preneoplastic foci. Environ Health Perspect 1993; 101 Suppl 5: 87-90.
39. Roskams T, Libbrecht L, Van Damme B, Desmet V. Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells? J Pathol 2000; 191: 150-3.
40. Kunzli BM, Berberat PO, Giese T, et al. Upregulation of CD39/NTP Dases and P2 receptors in human pancreatic disease. Am J Physiol Gastrointest Liver Physiol 2007; 292: G223-30.
41. Idzko M, Hammad H, van Nimwegen M, et al. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 2007; 13: 913-9.
42. Wang Y, Roman R, Lidofsky SD, Fitz JG. Autocrine signaling through ATP release represents a novel mechanism for cell volume regulation. Proc Natl Acad Sci U S A 1996; 93: 12020-5.
43. Pafundo DE, Mut P, Perez Recalde M, et al. Effects of extracellular nucleotides and their hydrolysis products on regulatory volume decrease of trout hepatocytes. Am J Physiol Regul Integr Comp Physiol 2004; 287: R833-43.
44. Pafundo DE, Chara O, Faillace MP, et al. Kinetics of ATP release and cell volume regulation of hyposmotically challenged goldfish hepatocytes. Am J Physiol Regul Integr Comp Physiol 2008; 294: R220-33.